These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17085798)

  • 1. beta2-Agonists at the Olympic Games.
    Fitch KD
    Clin Rev Allergy Immunol; 2006; 31(2-3):259-68. PubMed ID: 17085798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asthma medication in Finnish olympic athletes: no signs of inhaled beta2-agonist overuse.
    Alaranta A; Alaranta H; Palmu P; Alha P; Pietilä K; Heliövaara M; Helenius I
    Med Sci Sports Exerc; 2004 Jun; 36(6):919-24. PubMed ID: 15179158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of changes in the IOC-MC asthma criteria: a British perspective.
    Dickinson JW; Whyte GP; McConnell AK; Harries MG
    Thorax; 2005 Aug; 60(8):629-32. PubMed ID: 16061702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The asthmatic athlete, inhaled beta agonists, and performance.
    McKenzie DC; Stewart IB; Fitch KD
    Clin J Sport Med; 2002 Jul; 12(4):225-8. PubMed ID: 12131055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of exercise-induced asthma, respiratory and allergic disorders in sports and the relationship to doping: Part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA(2)LEN.
    Carlsen KH; Anderson SD; Bjermer L; Bonini S; Brusasco V; Canonica W; Cummiskey J; Delgado L; Del Giacco SR; Drobnic F; Haahtela T; Larsson K; Palange P; Popov T; van Cauwenberge P; ; ;
    Allergy; 2008 May; 63(5):492-505. PubMed ID: 18394123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchial challenges in athletes applying to inhale a beta2-agonist at the 2004 Summer Olympics.
    Anderson SD; Sue-Chu M; Perry CP; Gratziou C; Kippelen P; McKenzie DC; Beck KC; Fitch KD
    J Allergy Clin Immunol; 2006 Apr; 117(4):767-73. PubMed ID: 16630932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrimination of prohibited oral use of salbutamol from authorized inhaled asthma treatment.
    Bergés R; Segura J; Ventura R; Fitch KD; Morton AR; Farré M; Mas M; de La Torre X
    Clin Chem; 2000 Sep; 46(9):1365-75. PubMed ID: 10973867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic use exemptions (TUEs) at the Olympic Games 1992-2012.
    Fitch KD
    Br J Sports Med; 2013 Sep; 47(13):815-8. PubMed ID: 23591601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asthma and the elite athlete: summary of the International Olympic Committee's consensus conference, Lausanne, Switzerland, January 22-24, 2008.
    Fitch KD; Sue-Chu M; Anderson SD; Boulet LP; Hancox RJ; McKenzie DC; Backer V; Rundell KW; Alonso JM; Kippelen P; Cummiskey JM; Garnier A; Ljungqvist A
    J Allergy Clin Immunol; 2008 Aug; 122(2):254-60, 260.e1-7. PubMed ID: 18678340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?
    Kindermann W
    Sports Med; 2007; 37(2):95-102. PubMed ID: 17241101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes.
    Wolfarth B; Wuestenfeld JC; Kindermann W
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):75-87, ix. PubMed ID: 20122451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of asthma and airway hyper-responsiveness in Olympic athletes.
    Fitch KD
    Br J Sports Med; 2012 May; 46(6):413-6. PubMed ID: 22228581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled beta2 agonists and performance in competitive athletes.
    Kindermann W; Meyer T
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i43-7. PubMed ID: 16799103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The asthmatic athlete: inhaled Beta-2 agonists, sport performance, and doping.
    McKenzie DC; Fitch KD
    Clin J Sport Med; 2011 Jan; 21(1):46-50. PubMed ID: 21200170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical treatment of asthma symptoms in elite athletes - doping or therapy?
    Backer V; Lund T; Pedersen L
    Scand J Med Sci Sports; 2007 Dec; 17(6):615-22. PubMed ID: 18093034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asthma in elite athletes.
    Elers J; Pedersen L; Backer V
    Expert Rev Respir Med; 2011 Jun; 5(3):343-51. PubMed ID: 21702657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetic profile of inhaled and oral salbutamol in elite athletes with asthma and nonasthmatic subjects.
    Elers J; Pedersen L; Henninge J; Hemmersbach P; Dalhoff K; Backer V
    Clin J Sport Med; 2012 Mar; 22(2):140-5. PubMed ID: 22388343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes.
    Carlsen KH; Hem E; Stensrud T; Held T; Herland K; Mowinckel P
    Respir Med; 2001 Jul; 95(7):571-6. PubMed ID: 11453313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Responses to bronchial challenge submitted for approval to use inhaled beta2-agonists before an event at the 2002 Winter Olympics.
    Anderson SD; Fitch K; Perry CP; Sue-Chu M; Crapo R; McKenzie D; Magnussen H
    J Allergy Clin Immunol; 2003 Jan; 111(1):45-50. PubMed ID: 12532095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose inhaled salbutamol has no acute effects on aerobic capacity or oxygen uptake kinetics in healthy trained men.
    Elers J; Mørkeberg J; Jansen T; Belhage B; Backer V
    Scand J Med Sci Sports; 2012 Apr; 22(2):232-9. PubMed ID: 21083771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.